| AKANDA CORP. O.N. |
| Kanada |
| Gesundheit |
| CA00971M6018 / A41ZNG |
| Y231 (Frankfurt) / AKAN (NASDAQ) |
| FRA:Y231, ETR:Y231, Y231:GR, NASDAQ:AKAN |
| - |
| https://akandacorp.com/ |
|
Akanda Corp is a publicly traded company focused on the medical cannabis industry. It primarily engages in the cultivation, processing, and distribution of pharmaceutical-grade cannabis products for medicinal purposes. The company operates through it..
>Volltext.. |
| 1.21 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| AKANDA |
| 04.04.26 |
|